(2S)-N-(2-Benzoyl-4-chlorophenyl)-1-[(3,4-dichlorophenyl)methyl]-2-pyrrolidinecarboxamide

Catalog No. :
ACRPQE219
CAS No. :
1644308-41-7
Molecular Formula :
C25H21Cl3N2O2
Molecular Weight :
487.81

IUPAC Name:(S)-N-(2-benzoyl-4-chlorophenyl)-1-(3,4-dichlorobenzyl)pyrrolidine-2-carboxamide

(2S)-N-(2-Benzoyl-4-chlorophenyl)-1-[(3,4-dichlorophenyl)methyl]-2-pyrrolidinecarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$471.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S)-N-(2-Benzoyl-4-chlorophenyl)-1-[(3,4-dichlorophenyl)methyl]-2-pyrrolidinecarboxamide
IUPAC Name(S)-N-(2-benzoyl-4-chlorophenyl)-1-(3,4-dichlorobenzyl)pyrrolidine-2-carboxamide
Molecular FormulaC25H21Cl3N2O2
Molecular Weight487.81
SMILESO=C([C@H]1N(CC2=CC=C(Cl)C(Cl)=C2)CCC1)NC3=CC=C(Cl)C=C3C(C4=CC=CC=C4)=O
InChI KeyWLFWZUYAEFPRSE-QHCPKHFHSA-N
Synonym2-Pyrrolidinecarboxamide, N-(2-benzoyl-4-chlorophenyl)-1-[(3,4-dichlorophenyl)methyl]-, (2S)-
CAS No.1644308-41-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRPQE219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPQE219 route product structure diagram
    ACRPQE2191644308-41-7
Inquiry

2. ACRPQE219 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSOW189 route compound structure diagram
    ACXSOW189719-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPQE219 route product structure diagram
    ACRPQE2191644308-41-7
Inquiry

Comments (0)